Summary: A new study shows that metformin, a first-line diabetes treatment, may also significantly cut dementia risk. Studies also show that people with diabetes have a significantly higher dementia risk than healthy adults.
Diabetes is one of the most common metabolic disorders, and more people get it every year. Many problems are tied to diabetes, including chronic pain, dementia and diabetic neuropathy. Health experts sometimes call dementia type 3 diabetes for a reason. Still, dementia remains poorly understood. What is clear is that it has many causes. That is why preventing dementia and other neurodegenerative (brain-wasting) disorders is hard. The only way to lower the risk is through several lifestyle steps at once. For example, less exposure to pollutants may help cut your dementia risk. Better metabolic health may also lower the risk. But many people struggle to make big lifestyle changes. Now a study shows those people may benefit from metformin. Researchers had good reasons to look at metformin. First, people with diabetes face a higher risk of dementia. Dementia is almost twice as common in people with diabetes as in healthy people. That tells you dementia is tied to metabolic disorders, too. The second reason is how the drug works. Metformin is unlike other diabetes drugs. That is why it became a first-line treatment for diabetes. Other diabetes drugs do not lower insulin resistance; metformin does. It boosts energy production inside cells and prevents mitochondrial dysfunction (failure of the cell’s power plants). It also helps cut body weight. Other drugs work the opposite way. Sulfonylureas, for example, push the body to make more insulin. In recent years, evidence has been piling up that metformin may help cut dementia risk. Now one of the largest observational studies to date shows the benefit of metformin therapy is massive. It may cut dementia risk by almost 20% in people with diabetes. Sure, 20% may not sound big. But very few treatments lower dementia risk by any significant amount. So these numbers are not as small as they sound. Researchers looked at data on more than 110,000 adults with type 2 diabetes. All were older than 50 years. More than 96,000 were new metformin users, and a little more than 16,000 took sulfonylureas. In the metformin group, about 2.3% developed dementia. In the sulfonylurea group, about 5.8% developed dementia. The gap between the two groups was massive. They also checked whether metformin lowered the risk of other neurodegenerative disorders like Parkinson’s. They found no such association. About the same number of people got Parkinson’s in the metformin and sulfonylurea groups. The benefit was also stronger in people younger than 75. In very old adults, metformin helps less. That is expected. Mitochondrial damage is harder to prevent or reverse in older adults. The study has limits. It did not account for lifestyle or other confounding factors. Still, it opens the door to more research. The next question is whether metformin also cuts dementia risk in people without diabetes.
Frequently asked questions
Does metformin reduce dementia risk?
In people with type 2 diabetes, the evidence points that way. One of the largest observational studies to date followed more than 110,000 adults with type 2 diabetes, all older than 50. About 2.3% of new metformin users developed dementia. That compares with about 5.8% of people taking sulfonylureas. Overall, metformin was linked to a dementia risk almost 20% lower. Very few treatments move dementia risk at all.
Does diabetes increase the risk of dementia?
Yes. Dementia shows up almost twice as often in people with diabetes as in healthy adults. That is why some experts call dementia “type 3 diabetes.” The link tells you dementia is not only a brain problem; it is also a metabolic one. Better metabolic health is one of the few levers anyone has for lowering dementia risk.
Why would a diabetes drug protect the brain?
Metformin works differently from most diabetes drugs. Sulfonylureas push the pancreas to make more insulin. Metformin instead lowers insulin resistance and boosts energy production inside cells. It protects the mitochondria from breaking down and helps with weight loss. Those same failures, insulin resistance and failing mitochondria, are part of what ties diabetes to dementia. Treating them may protect the brain as well.
Does metformin lower dementia risk in older adults over 75?
Less so. The benefit was clearest in people younger than 75. In very old adults, metformin had a smaller edge. That fits the biology: mitochondrial damage is harder to prevent or reverse the older you get. The lesson is plain. Metabolic repair pays the most when it starts early, not after decades of damage have piled up.
Can metformin prevent dementia in people without diabetes?
Nobody knows yet. The study only looked at adults with type 2 diabetes. It did not account for lifestyle or other factors that could shape the result. It also found no effect on Parkinson’s disease. Whether metformin helps people without diabetes is the next question for researchers. Until then, lifestyle change and better metabolic health remain the main way to lower dementia risk.
The Takeaway Padda Institute of Pain Management has renowned specialists in the fields of diabetic neuropathy treatment and chronic pain treatment. Schedule an appointment now to achieve the life you desire.
Dr. Gurpreet Singh Padda, MD, MBA, MHP
